hawkowl

Setting up for the breakout

Long
OTC:RLFTF   RELIEF THERAPEUTICS HLDG AG
Potential 8 month base just starting it's move off the lower support line. Classic 4 point continuation pattern. Stochastics and MACD curling up.

Relief Therapeutics just held a conference call on concluding FDA Phase III trials for severe Covid using the drug Aviptadil (Zyesami). Expect filing for FDA EUA approval within a week and FDA approval in 30 days or less thereafter.